New treatment option for Free Gingival Graft
Official title Novel Soft Tissue Augmentation Technique Using Free Gingival Graft Simultaneous With Posterior Mandibular Implant
ClinicalTrials.gov ID: NCT06645925
What this study is testing
- What it's testing
- Presence of keratinized tissue (KT) around dental implants, plays a crucial role in stability and health of peri-implant tissues. Several studies reported that, minimum of 2 mm keratinized tissue width is required to achieve long-term longevity.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50. Healthy volunteers may be eligible.
You may be able to join if
- Adults at or above the age of 18.
- Lower Posterior missing tooth/ teeth with minimal KT \< 2mm
- Sufficient alveolar ridge length minimum 13-15 mm to IAN . Sufficient alveolar ridge width minimum of 6 mm
- Patients able to tolerate surgical periodontal procedures.
- Patients who provided an informed consent and accepted the one-year follow-up period.
You likely can't join if
- Patients diagnosed with periodontal diseases (Caton et al., 2018).
- Current or previous smokers.
- Pregnant and lactating females.
- Patients with medical conditions that would compromise the surgical procedures; uncontrolled diabetes mellitus, taking intravenous Bisphosphonates...
- Patients with active infection related to the site of implant.
- Patients with parafunctional habits.
See the full eligibility criteria
- Adults at or above the age of 18.
- Lower Posterior missing tooth/ teeth with minimal KT \< 2mm
- Sufficient alveolar ridge length minimum 13-15 mm to IAN . Sufficient alveolar ridge width minimum of 6 mm
- Patients able to tolerate surgical periodontal procedures.
- Patients who provided an informed consent and accepted the one-year follow-up period.
- Patients diagnosed with periodontal diseases (Caton et al., 2018).
- Current or previous smokers.
- Pregnant and lactating females.
- Patients with medical conditions that would compromise the surgical procedures; uncontrolled diabetes mellitus, taking intravenous Bisphosphonates for treatment of osteoporosis.
- Patients with active infection related to the site of implant.
- Patients with parafunctional habits.
- Patients with shallow vestibule
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.